echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Medical News > Latest Medical News > The State Food and Drug Administration approved the application for supplementation of production and capacity expansion of 5 symptomatic treatment drugs for new coronavirus infection, including ibuprofen tablets

    The State Food and Drug Administration approved the application for supplementation of production and capacity expansion of 5 symptomatic treatment drugs for new coronavirus infection, including ibuprofen tablets

    • Last Update: 2023-02-03
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com
    In order to further do a good job in the expansion and supply of symptomatic treatment drugs for new coronavirus infection, the State Food and Drug Administration recently approved supplementary applications
    for production expansion and expansion of 5 varieties including ibuprofen tablets through the rapid review channel.
    Among them, the production capacity of ibuprofen can be increased by 14 million pieces (bags)
    per day.
     
    Annex: List of varieties
    serial number
    Name of the drug
    Marketing Authorization Holder
    1
    Ibuprofen tablets
    Shandong Xinhua Pharmaceutical Co.
    , Ltd
    2
    Ibuprofen tablets
    Hubei Hengdi Pharmaceutical Co.
    , Ltd
    3
    Ibuprofen granules
    Hubei Hengdi Pharmaceutical Co.
    , Ltd
    4
    Ambroxol hydrochloride sodium chloride injection
    Anhui Shuanghe Pharmaceutical Co.
    , Ltd
    5
    Compound codeine phosphate solution (II)
    Luxembourg Big Pharma Ltd
    6
    Acetylcysteine solution for inhalation
    Hainan Star Pharmaceutical Co.
    , Ltd
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.